Search
Search titles only
By:
Search titles only
By:
Log in
Register
Search
Search titles only
By:
Search titles only
By:
Menu
Install the app
Install
Forums
New posts
All threads
Latest threads
New posts
Trending threads
Trending
Search forums
What's new
New posts
New ads
New profile posts
Latest activity
Free Ads
Latest reviews
Search ads
Members
Current visitors
New profile posts
Search profile posts
Contact us
Latest ads
AI Chat Bot for Websites
sajith.xp.pk
Updated:
Yesterday at 1:17 PM
Puffin Rock Characters Plush Toy Set
anil1961
Updated:
Nov 7, 2026
Toyota Vitz scp10 For Sale
Lakmal Bandara
Updated:
Nov 4, 2026
Kandy
Welcome all my all new pet shop Bark.lk
dilumrane
Updated:
Nov 2, 2026
Windows RDP Only Rs.500 a month
Blogerwiki
Updated:
Nov 1, 2026
Electronics
Vehicles
Property
Search
Reply to thread
Forums
General
ElaKiri Talk!
FDA approves mRNA Flu Vaccine
Get the App
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Message
<blockquote data-quote="imhotep" data-source="post: 31549503" data-attributes="member: 562115"><p>The U.S. Food and Drug Administration (FDA) has approved the first flu vaccine built on messenger RNA (mRNA) technology, months after the agency refused to even consider the application. The shot, called mFLUSIVA, is made by Moderna and was cleared on Wednesday.</p><p></p><p>Approval covers adults ages 50 to 64. Adults 65 and older fall under an accelerated approval, which permits broad use now and can be upgraded to a full approval if a follow-up study delivers acceptable results.</p><p></p><p>It's said to be superior to the current flu vaccines. Researchers compared rates of influenza diagnosis in more than 40 000 participants who received either Moderna’s trivalent mRNA-1010 vaccine or the standard flu jab over several months in the 2024-25 flu season. All participants were aged 50 or older.</p><p></p><p>The results showed that 2% (411 of 20 179) of people who had the Moderna vaccine and 2.8% (557 of 20 124) in the standard group developed flu. This equated to Moderna’s shot being 26.6% (95% confidence interval 16.7% to 35.4%) more effective than the standard dose flu shot from GSK (GSK.L), meeting the study’s criterion that Moderna’s jab should be at least as effective as existing approved vaccines.</p></blockquote><p></p>
[QUOTE="imhotep, post: 31549503, member: 562115"] The U.S. Food and Drug Administration (FDA) has approved the first flu vaccine built on messenger RNA (mRNA) technology, months after the agency refused to even consider the application. The shot, called mFLUSIVA, is made by Moderna and was cleared on Wednesday. Approval covers adults ages 50 to 64. Adults 65 and older fall under an accelerated approval, which permits broad use now and can be upgraded to a full approval if a follow-up study delivers acceptable results. It's said to be superior to the current flu vaccines. Researchers compared rates of influenza diagnosis in more than 40 000 participants who received either Moderna’s trivalent mRNA-1010 vaccine or the standard flu jab over several months in the 2024-25 flu season. All participants were aged 50 or older. The results showed that 2% (411 of 20 179) of people who had the Moderna vaccine and 2.8% (557 of 20 124) in the standard group developed flu. This equated to Moderna’s shot being 26.6% (95% confidence interval 16.7% to 35.4%) more effective than the standard dose flu shot from GSK (GSK.L), meeting the study’s criterion that Moderna’s jab should be at least as effective as existing approved vaccines. [/QUOTE]
Insert quotes…
Verification
Hata thunen beduwama keeyada? (60 bedeema thuna)
Post reply
Top
Bottom